Post-MI Secondary Prevention and Cardiac Rehabilitation
On this page
Direct answer
Secondary prevention after myocardial infarction is the long-term treatment that stops a second heart attack, stroke or cardiac death. It rests on aspirin with a P2Y12 inhibitor for the first months, a high-intensity statin, and beta-blockers and renin-angiotensin blockers where the ejection fraction is reduced. Smoking cessation, blood pressure and glucose control and supervised cardiac rehabilitation complete the package.
What you must remember
- Antiplatelet pair: aspirin plus a P2Y12 inhibitor such as clopidogrel, ticagrelor or prasugrel, with the P2Y12 drug usually continued for about 12 months after an acute coronary syndrome and shortened only when bleeding risk is high.
- Statin: high-intensity therapy from the first days, such as atorvastatin 80 mg or rosuvastatin 20 to 40 mg, aiming at a lower LDL cholesterol target in very high-risk patients.
- Beta-blocker: long-term use benefits patients with reduced ejection fraction or heart failure, and it is withheld in cardiogenic shock or high-degree heart block.
- ACE inhibitor or ARB: indicated after infarction with reduced ejection fraction, heart failure, diabetes or hypertension, and it limits adverse remodelling.
- Mineralocorticoid antagonist: added when ejection fraction is 40 percent or less with heart failure or diabetes, with potassium and creatinine monitoring.
- Cardiac rehabilitation: supervised exercise, education and psychological support, in phase I in hospital, phase II as an outpatient programme and phase III as lifelong maintenance.
- Avoid: regular NSAIDs, which raise the risk of recurrent events and renal injury; paracetamol is the safer analgesic.
A pathway from the coronary care unit to lifelong review
A 58-year-old man with diabetes is discharged after an anterior STEMI treated with primary PCI. His ejection fraction is 35 percent and his LDL cholesterol is 140 mg/dL.
- Start the antiplatelet pair. Aspirin continues indefinitely, and the P2Y12 inhibitor runs for the protocol duration, with a proton pump inhibitor added where gastrointestinal bleeding risk is high.
- Intensify the statin at once. Atorvastatin 80 mg or high-intensity rosuvastatin is started without waiting for titration, and LDL is rechecked after about 4 to 12 weeks.
- Add the heart failure drugs. A beta-blocker, an ACE inhibitor or ARB and a mineralocorticoid antagonist are titrated to tolerance, since his ejection fraction is below 40 percent.
- Control the other risks. Blood pressure and glucose are targeted, and smoking cessation is supported with nicotine replacement or varenicline.
- Enrol in phase II rehabilitation. A supervised outpatient programme of exercise and education, usually run over several weeks, is arranged at discharge.
- Reassess the ejection fraction. An echocardiogram after recovery decides whether an implantable defibrillator is needed, because an ejection fraction persisting at or below 35 percent is the usual threshold.
Where the exam tries to catch you
Three errors recur in post-infarction questions.
- Trap: stopping the P2Y12 inhibitor early because the patient feels well Correct: premature withdrawal is a leading cause of stent thrombosis, so duration follows the protocol rather than symptoms.
- Trap: leaving out an ACE inhibitor when blood pressure is normal Correct: with reduced ejection fraction, heart failure or diabetes it is indicated for its effect on remodelling and events, even at normal pressure.
- Trap: prescribing NSAIDs for post-procedure pain Correct: NSAIDs raise recurrent cardiac event and renal risk, so paracetamol is preferred.
Frequently asked questions
Which antiplatelet combination is standard after an acute coronary syndrome?
Aspirin combined with a P2Y12 inhibitor, usually clopidogrel, ticagrelor or prasugrel, is the standard dual antiplatelet combination after an acute coronary syndrome. The choice of P2Y12 drug and its duration depend on the type of event, whether a stent was placed and the bleeding risk.
Which drugs reduce mortality after myocardial infarction with reduced ejection fraction?
Beta-blockers, ACE inhibitors or ARBs, and mineralocorticoid antagonists reduce mortality after myocardial infarction with reduced ejection fraction. SGLT2 inhibitors are added for heart failure or diabetes, and sacubitril-valsartan is an option in selected patients with heart failure.
What is the role of cardiac rehabilitation after myocardial infarction?
Cardiac rehabilitation is a multidisciplinary programme of supervised exercise, risk-factor education and psychological support. It improves functional capacity and lowers recurrent events, and it is recommended after an acute coronary syndrome whether or not a stent was placed.
When should a high-intensity statin be started after myocardial infarction?
High-intensity statin therapy should start early after myocardial infarction, without waiting for a lipid result or dose titration. Atorvastatin 80 mg and rosuvastatin 20 to 40 mg are the high-intensity options in standard textbooks.